1 min read

Lupin Receives USFDA Nod, Aether Industries Opens New Plant, and Sula Reports Record Profits

Lupin has received tentative approval from the US Food and Drug Administration for a new tablet to treat HIV. Aether Industries is set to open a new manufacturing facility in Surat with 3,500 million tonnes of capacity. Sula shares rose 14% as the company reported robust Q3 numbers with own brand sales up 13%. Global markets have risen with the Nikkei 225 up 1.29%.

Lupin has received tentative approval from the US Food and Drug Administration (USFDA) for Dolutegravir and Rilpivirine tablets, used for HIV treatment. Annual sales for the tablets are estimated to be around $666 million (September 2022). This news comes alongside Aether Industries’ announcement of a new manufacturing facility in Surat, set to open for operations within the next ten days. The facility will add a capacity of 3,500 million tonnes and cost ₹190 crore, of which 163 crore was raised through the IPO route.

Shares of India’s largest wine producer and seller, Sula, rose 14% after it reported robust Q3 numbers. Own brand sales rose 13% year-on-year to ₹187 crore, while wine tourism business reported revenue growth of 13% to ₹23 crore. This news is a positive sign for the company, and comes as global markets have been rising, with the Nikkei 225 up 1.29%, and the Dow Jones, NYSE, and Nasdaq all seeing varying rises and falls.

An interesting fact of the day is that 1% of the richest people in India own more than 40% of the wealth in the country. This statistic is a stark reminder of the large wealth disparity in the country, and highlights the need for better economic policies to ensure that wealth is more evenly distributed.

Leave a Reply

Latest from Blog

DISCLAIMER

Kindaily is completely generated using AI. The content of the news may not be accurate. Kindaily is made for entertainment only so that we can enjoy the amazing capabilities of AI. If you feel any content is inappropriate immediately inform us at support@kindaily.com. We will take action. Till then, Enjoy with a light heart!

About us

Kindaily is an AI-powered news paper developed by Avifa Infotech Pvt Ltd. Uniquely, all articles and images are generated by AI using advanced language model ChatGPT and DALL-E technology. The articles are short, easy to read and provide a fresh, innovative and technologically advanced way of reading news. Kindaily is the future of news consumption. Experience the news through the lens of AI.

FOLLOW US

Join us on social media to checkout our unique posts that we share on these platforms. 

Copyright 2023. All Rights Reserved.
Created by Avifa Infotech Pvt. Ltd.

Join Kindaily!
  • Relevant news based on your reading preferences
  • Daily digest of our best stories 
  • Unlimited access to our site and app
Written and Illustrated by AI
Join Kindaily
Unlimited Access. Daily Digest. Personalized and relevant news. Summarized and illustrated by AI
Download The Kindaily App
  • Enjoy Easy Reading
  • Curated For You
  • Stay Upto Date
%d bloggers like this: